Symbiotec Pharmalab: Revised Promoter Share Encumbrance Disclosure

Symbiotec Pharmalab Limited has filed a revised disclosure regarding the encumbrance of shares by promoter Anil Satwani, as per SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. The revision clarifies the entity in whose favor the shares are encumbered, specifying Nomura Capital (India) Private Limited as the Lender and Beacon Trusteeship Limited as the Trustee. This update pertains to the re-creation of a pledge for debentures issued under a Debenture Trust Deed, involving 4,50,896 shares (0.70% of total share capital). The original disclosure was filed on September 12, 2026, with the revised filing dated October 16, 2026.